BMS-929075

DB14950InvestigationalSmall molecule

BMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).

Formula / weight: C₃₁H₂₄F₂N₄O₃ · 538.555 g/mol (avg)
Code names: BMS-929075

Resolves to

Compound

UNII8S38482CSTCAS1217338-97-0ChEMBLCHEMBL4093031

Structure

InChIKeyLZAUGCMVNLZVJV-UHFFFAOYSA-NSMILESCNC(=O)C1=C(OC2=C1C(F)=C(C=C2)C1=C(C)C=CC(=C1)C(=O)NC1(CC1)C1=NC=CC=N1)C1=CC=C(F)C=C1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of BMS-929075, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account